180 Life Sciences WarrantATNFW
About: 180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
Employees: 2
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
41% more capital invested
Capital invested by funds: $474 [Q4 2024] → $669 (+$195) [Q1 2025]
2.45% more ownership
Funds ownership: 6.19% [Q4 2024] → 8.65% (+2.45%) [Q1 2025]
20% less funds holding
Funds holding: 5 [Q4 2024] → 4 (-1) [Q1 2025]
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Research analyst outlook
We haven’t received any recent analyst ratings for ATNFW.
Financial journalist opinion
We haven’t received any recent news articles for ATNFW.